Formulation Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
| |
Unit Size 100 µg | |
Storage Instructions Aliquot and store at -20°C. Minimize freezing and thawing. | |
Synonym / Alias Names ERV3|H-PLK|HERV-R|ERV-R|ERV-3 envelope protein|envelope polyprotein|endogenous retroviral sequence 3 (includes zinc finger protein H-plk/HPF9)|endogenous retroviral sequence 3 | |
Accession ID NP_001007254.2 | |
Blocking Peptide EBP10499 | |
Immunogen Peptide with sequence C-PQDNFTLTASS, from the internal region of the protein sequence according to NP_001007254.2. | |
Peptide Sequence C-PQDNFTLTASS | |
Purification Method Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. | |
Shipping Instructions Refrigerated | |
Predicted Species Human | |
Reactive Species Human | |
Human Gene ID 2086 | |
Product Grade  | |
IHC Results Paraffin embedded Human Placenta. Recommended concentration: 3.75µg/ml. This product has been successfully used in IHC on Human: Frese S et al, PLoS One. 2015 Jul 8;10(7). PMID: 26154387. | |
ELISA Detection Limit Antibody detection limit dilution 1:4000. | |
Western Blot This product has been successfully used in WB on Human: Nahas MR et al,, (2019) Br. J. Haematol., May;185(4):679-690. PMID: 30828801. | |
Application Type Pep-ELISA, WB, IHC |
Goat Anti-ERV3 Antibody
$423.00
| SKU | Unit Size | Price |
|---|---|---|
Select a unit size:
Selected References [{"pmid": 26154387, "intro": "This antibody has been successfully used in IHC on Human:", "title": "Long-Term Endurance Exercise in Humans Stimualtes Cell Fusion of Myoblasts along with Fusogenic Endogenous Retroviral Genes In Vivo.", "author": "Frese S, Ruebner M, Suhr F, Konou TM, Tappe KA, Toigo M, Jung HH, Henke C, Steigleder R, Strissel PL, Huebner H, Beckmann MW, van der Keylen P, Schoser B, Schiffer T, Frese L, Bloch W, Strick R.", "journal": "PLoS One. 2015 Jul 8;10(7)."}, {"pmid": 30828801, "intro": "This antibody has been successfully used in Western blot on Human:", "title": "Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine", "author": "Nahas MR, Stroopinsky D, Rosenblatt J, Cole L, Pyzer AR, Anastasiadou E, Sergeeva A, Ephraim A, Washington A, Orr S, McMasters M, Weinstock M, Jain S, Leaf RK, Ghiasuddin H, Rahimian M, Liegel J, Molldrem JJ, Slack F, Kufe D, Avigan D", "journal": "Br J Haematol. 2019 May;185(4):679-690."}] |